UPDATED Sep 29, 2025
Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VSC | €0.81 | -3.8% | -85.3% | €9.2m | n/a | PS43.7x | n/a | n/a | ||
DADI | د.أ1.15 | -0.9% | -7.3% | د.أ40.6m | n/a | PE9.7x | n/a | 0% | ||
CLRB | US$5.41 | -2.0% | -91.6% | US$17.6m | US$47.00 | PB3.1x | E23.3% | n/a | ||
KNB | UK£0.0022 | -25.0% | -82.0% | UK£1.4m | n/a | PS1.2x | n/a | n/a | ||
EPIX | US$0.19 | -3.8% | -96.8% | US$9.5m | n/a | PB0.08x | n/a | 874.4% | ||
ZEOX | US$1.35 | -2.0% | -42.6% | US$18.1m | n/a | PS3.7x | n/a | n/a | ||
ESLA | US$1.19 | -0.8% | 2.6% | US$44.5m | US$16.00 | PE-3.7x | E56.7% | n/a | ||
OTLC | US$0.071 | -1.2% | 238.7% | US$31.5m | n/a | PB3.7x | n/a | n/a | ||
CRIS | US$1.66 | -1.8% | -69.2% | US$21.1m | US$16.33 | PS1.8x | E16.5% | n/a | ||
IXC | AU$0.15 | -3.1% | 106.7% | AU$12.0m | n/a | PS50.8x | n/a | n/a | ||
APUS | US$1.90 | -1.6% | n/a | US$24.3m | n/a | PB2.5x | n/a | n/a | ||
SNGX | US$1.11 | -7.5% | -72.0% | US$5.1m | US$22.50 | PB2.6x | E-11.1% | n/a | ||
RAMM | CA$0.01 | -33.3% | -50.0% | CA$1.2m | n/a | PB0.1x | n/a | n/a | ||
MOC | zł7.43 | -0.3% | -43.7% | zł150.1m | zł18.25 | PS43x | E44.2% | n/a | ||
CBIH | US$0.00047 | -7.0% | -33.6% | US$5.8m | n/a | PS17.8x | n/a | n/a | ||
ADXN | CHF 0.06 | -7.1% | -10.7% | CHF 5.9m | n/a | PS24.1x | S62.6% | n/a | ||
IMUX | US$0.93 | -0.5% | -43.3% | US$92.6m | US$6.83 | PB2.7x | E61.8% | n/a | ||
NYMX.F | US$0.045 | -9.0% | -62.1% | US$4.7m | n/a | PE-1x | n/a | n/a | ||
GOVX | US$0.63 | -2.6% | -73.9% | US$16.4m | US$10.38 | PS2.6x | E60.6% | n/a | ||
PROGEN | SEK 0.58 | -2.0% | -95.6% | SEK 21.3m | n/a | PS29.8x | n/a | n/a | ||
KZR | US$3.59 | -1.6% | -53.6% | US$26.7m | US$12.50 | PB0.3x | E-8.8% | n/a | ||
VERU | US$3.70 | -0.8% | -51.9% | US$54.6m | US$19.75 | PS3.2x | E14.3% | 0% | ||
NIRV | CA$0.03 | -64.7% | n/a | CA$684.7k | n/a | PE-2x | n/a | n/a | ||
PHRM | CA$0.38 | -1.3% | 31.6% | CA$34.6m | n/a | PB35.1x | n/a | n/a |